VIENNA - Wednesday, 24. January 2024
– a new treatment option for Huntington’s Disease patients
(BUSINESS WIRE) -- HD Immune GmbH (HDI), a privately held biotechnology company developing novel antibody treatments for Huntington’s Disease, announces commencement of operations by its two fou…